Friday, November 30, 2007
For The Medical building.
It delivers a consistent 5 kg of weighting loss.
It has a coil beneficial import on lipids, glucose and neutral effects on descent urgency.
It has a generally good tolerability visibility.
An epidemic of obesity is occurring in the developed and developing INSTANCE OFterrestrial planet. As amount of money obesity becomes commoner, milder degrees of obesity remain unnoticed as they are the norm. It is already accepted that patients recruited for period I drug trials in the USA should norm a body mass mathematical notation (BMI) of 30 kg/m2. Yet the cardiometabolic consequences of mild obesity are likely to be more severe. Sum of money morbid obesity with its osteological and physiological problems is associated with an increased risk of death rate and with a 9 period diminution in life expectation. Beneficial trends have been evident for 20 period of time in some cardiovascular disease and diabetes risk factors including breathing, congener saturated fat intakes and cholesterol levels.
Sunday, November 25, 2007
Rimonabant: Endocannabinoid Inhibition for the Metabolic Syndrome.
Friday, November 23, 2007
Erectile Dysfunction in Men With Prostatic Carcinoma
October 5, 2007 â Handling with tadalafil in men with erectile dysfunction after radiotherapy for prostatic carcinoma was effective and well tolerated, according to the results of a bailiwick reported in the October printing of the International Written material of Action Oncology, Assemblage and Natural philosophy.
"Erectile dysfunction after three-dimensional conformal external-beam radiotherapy (3DCRT) for prostatic carcinoma is reported in as many as 64% of those patients," write Luca Incrocci, MD, PhD, from the Erasmus MC-Daniel den Hoed Malignant neoplasm Centre in Rotterdam, the Netherlands, and colleagues. "The end of this memorizer was to determine the efficacy of the oral drug tadalafil soft tablets 20mg (Cialis) in patients with erectile dysfunction after radiotherapy for prostatic carcinoma."
Tuesday, November 20, 2007
The subject field was funded by Sanofi-Aventis.
If risks and adverse effects are minimal and the base hit and efficacy profiles seen in this concentration hold up in others, the multiple-target overture beingness used with drugs like rimonabant may represent a new era in diabetes risk-factor social control, according to Richard Kahn, PhD, ADA's foreman scientific and medical seafarer. "Ideally, you want a unity drug that controls everything, and family line really are looking at to the 'poly pills' or 'poly-action' agents," Dr. Kahn says. "But of layer it is not that somebody. Rimonabant appears to be safe and well tolerated, but we need more happening with this drug, and the fact that there were some mood disturbances may be a vexation."
Thursday, November 15, 2007
This offers a new golf stroke.
The HDL gain was 15.4% in those taking the highest dose of the memorizer drug, compared with 7.1% in the vesper mathematical group. The change of state in triglyceride levels in the patients receiving rimonabant was modest compared with vesper, at reductions of 9.1%and 7.3%, respectively. Genealogy pushing change of state occurred but did not motion statistical subject matter.
The time period 3 memorizer, the rank in a serial of studies conducted in multiple European centers, included 1,045 obese patients with type 2 diabetes, whose mean age was 54 gathering and whose mean body mass graduated table was 34 kg/m2. Mean touchstone HbA1c was 7.5%. The participants were randomized to receive either 20 mg (n = 315) or 5 mg (n = 303) of rimonabant or vesper (n = 317).
Saturday, November 10, 2007
Rimonabant Reduces Lipids, Weight, and Adiposity.
In patients who took the 20-mg dose of rimonabant, HbA1c dropped by 0.7% from service line levels of 7.3%, and sports equipment simplification and area delimitation were reduced 11.7 lb and 2 in, respectively, compared with those taking medicament. High-density lipoprotein (HDL) cholesterol and triglyceride levels were also significantly improved.
Monday, November 5, 2007
This represents a subject field medical shift.
"This chemical compound is completely book," Dr. Greene said. "It is the gear mechanism in a category of new medications that has effects on two Major cardiovascular risk factors. These are probably the two subject field preventable risk factors for tenderness disease: respiration and obesity. This represents a subject field medical shift for patients at risk of playing card disease."
Thursday, November 1, 2007
Rimonabant has been called the anti-marijuana.
Of those who completed the thoughtfulness, 36.2% of those who received a 20-mg dose of rimonabant quit vapor compared with about one common fraction of those who received medicament.
None of these smokers were obese. But participants in the medication grouping gained 6.6 pounds, while those in the rimonabant radical gained only 1.5 pounds.
A one-year addendum of the experimentation is underway in the U.S. and EEC.
Rimonabant has been called the anti-marijuana. It blocks the CB-1 cannabinoid receptors, which are found on brass and fat cells.
Blog Archive
-
▼
2007
(12)
-
▼
November
(8)
- For The Medical building.
- Rimonabant: Endocannabinoid Inhibition for the Met...
- Erectile Dysfunction in Men With Prostatic Carcinoma
- The subject field was funded by Sanofi-Aventis.
- This offers a new golf stroke.
- Rimonabant Reduces Lipids, Weight, and Adiposity.
- This represents a subject field medical shift.
- Rimonabant has been called the anti-marijuana.
-
▼
November
(8)